Literature DB >> 20888975

Ovarian cancer: relevant therapy, not timing, is paramount.

Robert T Morris1, Bradley J Monk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888975     DOI: 10.1016/S0140-6736(10)61515-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Utility of paraneoplastic antigens as biomarkers for surveillance and prediction of recurrence in ovarian cancer.

Authors:  Madhumita Chatterjee; Laura C Hurley; Nancy K Levin; Matthew Stack; Michael A Tainsky
Journal:  Cancer Biomark       Date:  2017-12-06       Impact factor: 4.388

2.  Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125.

Authors:  Michèl Schummer; Charles Drescher; Robin Forrest; Shirley Gough; Jason Thorpe; Ingegerd Hellström; Karl Erik Hellström; Nicole Urban
Journal:  Gynecol Oncol       Date:  2011-12-07       Impact factor: 5.482

3.  Tumor autoantibodies as biomarkers for predicting ovarian cancer recurrence.

Authors:  Madhumita Chatterjee; Greg Dyson; Nancy K Levin; Jay P Shah; Robert Morris; Adnan Munkarah; Michael A Tainsky
Journal:  Cancer Biomark       Date:  2012       Impact factor: 4.388

Review 4.  Ovarian cancer.

Authors:  Ursula A Matulonis; Anil K Sood; Lesley Fallowfield; Brooke E Howitt; Jalid Sehouli; Beth Y Karlan
Journal:  Nat Rev Dis Primers       Date:  2016-08-25       Impact factor: 52.329

Review 5.  Clinically Meaningful Use of Blood Tumor Markers in Oncology.

Authors:  Stefan Holdenrieder; Lance Pagliaro; David Morgenstern; Farshid Dayyani
Journal:  Biomed Res Int       Date:  2016-11-30       Impact factor: 3.411

6.  GyneScan: an improved online paradigm for screening of ovarian cancer via tissue characterization.

Authors:  U Rajendra Acharya; S Vinitha Sree; Sanjeev Kulshreshtha; Filippo Molinari; Joel En Wei Koh; Luca Saba; Jasjit S Suri
Journal:  Technol Cancer Res Treat       Date:  2013-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.